{"id":795751,"date":"2026-07-12T15:56:09","date_gmt":"2026-07-12T15:56:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/795751\/"},"modified":"2026-07-12T15:56:09","modified_gmt":"2026-07-12T15:56:09","slug":"quality-guidelines-needed-for-prevention-and-diagnosis-of","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/795751\/","title":{"rendered":"Quality guidelines needed for prevention and diagnosis of\u2026"},"content":{"rendered":"<p>The five-year relative survival rate for\u00a0<a href=\"https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-data-in-australia\/contents\/summary-dashboard\" rel=\"nofollow noopener\" target=\"_blank\">vaginal and vulval cancers<\/a> (53% and 74%, respectively) are much lower than for more common women\u2019s cancers such as breast (93%) and endometrial (84%) cancers. The reasons for poorer survival are multifactorial but likely stem in part from the rarity of these cancers. In 2025, there were only 117 new cases of vaginal cancers and 401 new cases of vulvar cancers diagnosed in Australia. This means that clinicians are less likely to be familiar with their diagnosis and management.\u00a0For example, general practitioners might only ever see one, or no, cases during their career. These cancers are also challenging to diagnose due to a lack of specific symptoms and early detection screening tests. Improved understanding and awareness of these rarer cancers may help improve clinical assessment, which can help to prevent and diagnose these cancers. This improved understanding and awareness can come in the form of additional education and guidance for clinicians.<\/p>\n<p>For more common cancers, such as <a href=\"https:\/\/www.cancer.org.au\/assets\/pdf\/cervical-cancer-optimal-cancer-care-pathway\" rel=\"nofollow noopener\" target=\"_blank\">cervical<\/a>,\u00a0<a href=\"https:\/\/www.cancer.org.au\/assets\/pdf\/endometrial-cancer-2nd-edition\" rel=\"nofollow noopener\" target=\"_blank\">endometrial<\/a> and\u00a0<a href=\"https:\/\/www.cancer.org.au\/assets\/pdf\/ovarian-cancer-2nd-edition\" rel=\"nofollow noopener\" target=\"_blank\">ovarian cancers<\/a>,\u00a0<a href=\"https:\/\/www.canceraustralia.gov.au\/national-optimal-care-pathways-framework\" rel=\"nofollow noopener\" target=\"_blank\">Optimal Care Pathways<\/a> (OCPs) have been developed to provide national standards for quality and equitable care across the cancer continuum. While research is not available across all cancers, it has been shown, for example, that care consistent with the OCP for colorectal cancer was associated with improved survival in\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31709413\/\" rel=\"nofollow noopener\" target=\"_blank\">colon cancer<\/a> patients, independent of new diagnostic tests or treatments, lower disease stage at diagnosis and lower likelihood of emergency surgery. At this time, an OCP is not yet available for vaginal and vulvar cancers,<\/p>\n<p>To understand the resources available to support vaginal and vulvar cancers prevention and diagnosis\u00a0we conducted a <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40998029\/\" rel=\"nofollow noopener\" target=\"_blank\">systematic review<\/a> to identify, evaluate and synthesise current guidelines (within the past 10 years)\u00a0on diagnostic pathways for women with vaginal and vulvar cancers. Diagnosis and prevention were the focus of this review, with staging and treatment beyond the scope of this review. We included evidence-based and consensus-based guidelines relevant to the first three stages of the Optimal Care Pathways:<\/p>\n<p>prevention and early detection;\u00a0presentation, initial investigations and referral; and\u00a0diagnosis.Existing guidelines included in our review<\/p>\n<p>Overall, we identified 45 guidelines internationally; two were developed in Australia. The two guidelines developed in Australia were published by the Chris O\u2019Brien Lifehouse for vaginal and vulvar cancers. While GPs can access these two guidelines, they are now 10 years old and should be viewed with this in mind. More of the guidelines addressed vulvar cancer (62%) than vaginal cancer (22%), with 16% addressing both types of cancers. Most guidelines covered prevention and early detection (82%), but only about half mentioned presentation, initial investigations and referral (53%) or diagnosis (51%).<\/p>\n<p>Consistent recommendations were identified<\/p>\n<p>    Prevention and early detectionHPV vaccinationShould help prevent precursor conditions (e.g., vaginal intraepithelial neoplasia (VIN)) and therefore vaginal and vulvar cancerOpportunistic screeningCervical screening offers the opportunity to diagnose these cancers and their precursors with visual examinationBiopsyWarranted if lesions do not resolve or are suspected to be invasive.Diagnosis\u00a0HistoryClinicians should take patients\u2019 medical histories as part of the diagnostic processPhysical evaluationIncluding inspection of the vulvar and pelvic examination\u00a0TestingCytology testing (+ HPV testing), plus blood testsReferralReferral to health professionals<\/p>\n<p>Refer concerning lesions to an appropriate clinician for biopsy (e.g. gynaecologist)<\/p>\n<p>Refer if cytology results or visual examinations are abnormal.<\/p>\n<p>Further investigations<\/p>\n<p>Investigate therapy-resistant vulvar symptoms persisting for several weeks.<\/p>\n<p>Specialist work-up should include colposcopy, biopsy for histopathologic confirmation plus endometrial evaluation (vulvar cancer).<\/p>\n<p>Timeframe28 days from urgent General Practitioner referral for suspected vaginal or vulvar cancer to either receiving a diagnosis or ruling out cancer (National Institute for Health and Care Excellence, 2026)<\/p>\n<p>    What\u2019s missing from current guidelines?<\/p>\n<p>Views and Preferences of Consumers: Few guidelines incorporated the views and preferences of consumers (ie, people with a lived experience).\u00a0For guidelines to be useful across a range of settings, consumers from identified priority groups should be included during the development of Optimal Care Pathways. This may assist with addressing known inequities.\u00a0Examples of priority population groups, as identified by The <a href=\"https:\/\/www.australiancancerplan.gov.au\/welcome\" rel=\"nofollow noopener\" target=\"_blank\">Australian Cancer Plan<\/a>, include Aboriginal and Torres Strait Islander people, people living in rural and remote areas and older Australians.<\/p>\n<p>Applicability: Guidelines were rated low in terms of applicability. They could include the following to improve applicability of the recommendations and statements for the diagnosis of vaginal and vulvar cancers:<\/p>\n<p>Address facilitators and barriers to implementing the recommendations;Provide advice on how recommendations can be put into practice;Describe the potential resource implications;Methods for monitoring guideline uptake.<\/p>\n<p>In Australia, the creation of a OCP for vaginal and vulvar cancers could help improve current practices, combining existing evidence and expert opinion presented in guidelines. OCPs can address limitations of current guidelines by including consumers in developing OCPs, providing additional recommendations specific to priority populations, and providing guidance for implementation into clinical practice. Guidelines should be culturally appropriate. Recommendations should be consistent and specific timeframes need to be outlined for diagnosis.<\/p>\n<p>Implications for clinical practice and future development of OCPs\u00a0<\/p>\n<p>Current screening practices should be evaluated prior to creating new OCPs. While the <a href=\"https:\/\/www.health.gov.au\/our-work\/national-cervical-screening-program\" rel=\"nofollow noopener\" target=\"_blank\">National Cervical Screening Program<\/a> aims to reduce the impact of cervical cancer, it also offers the opportunity to detect cancers and their precursors through visual examination of the vulva and vagina. While self-collection for HPV screening is an <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0091743521004734?via%3Dihub\" rel=\"nofollow noopener\" target=\"_blank\">effective strategy<\/a> to reach under- and never-screened women, it limits opportunities for incidental findings during physical exams. The impact of self-collection on HPV-independent cases (eg, identified from visual inspection not HPV testing) should be considered.<\/p>\n<p>An OCP for vaginal and vulvar cancers can help support GPs in clinical practice, providing clear, standardised pathways for prevention and detection. <a href=\"https:\/\/www.rarecancers.org.au\/ocp-working-group\/\" rel=\"nofollow noopener\" target=\"_blank\">Rare Cancers Australia<\/a> are currently developing an OCP for people with rare and less common cancers and it would be beneficial to keep updated with this pathway as it develops.<\/p>\n<p>Ms Ambika Aul is a recent Bachelor of Health Sciences (Honours) graduate from the University of Queensland, with her honour\u2019s thesis focusing on gynaecological cancer epidemiology. She recently published her first paper which looked at assessing guidelines for the prevention and diagnosis of vaginal and vulvar cancers.<\/p>\n<p>Professor Susan Jordan is a medically trained epidemiologist and NHMRC Leadership Fellow\u00a0 at the University of Queensland School of Public Health, where she leads a team investigating aetiology and patterns of care in gynaecological and endocrine cancers.<\/p>\n<p>Dr Tracey DiSipio is a cancer epidemiologist in the School of Public Health, The University of Queensland. Her program of research is focused on improving outcomes for women with gynaecological cancer by conducting consumer-informed epidemiological research and behavioural interventions that address survivorship issues. Her research has a strong emphasis on under-researched groups including women diagnosed with vaginal and vulvar cancer.<\/p>\n<p>&#13;<br \/>\n   The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.\u00a0\u00a0&#13;\n<\/p>\n<p>The statements or opinions expressed in this article reflect the views of the authors and do not necessarily represent the official policy of the AMA, the\u00a0MJA\u00a0or\u00a0InSight+\u00a0unless so stated.\u00a0<\/p>\n<p>Subscribe to the free\u00a0InSight+\u00a0weekly newsletter\u00a0<a href=\"https:\/\/insightplus.mja.com.au\/insight-signup\" target=\"_blank\" rel=\"nofollow noopener\">here<\/a>. It is available to all readers, not just registered medical practitioners.\u00a0<\/p>\n<p>If you would like to submit an article for consideration, send a Word version to\u00a0<a href=\"https:\/\/insightplus.mja.com.au\/2026\/27\/mailto:mjainsight-editor@ampco.com.au\" target=\"_blank\" rel=\"nofollow noopener\">mjainsight-editor@ampco.com.au<\/a>.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"The five-year relative survival rate for\u00a0vaginal and vulval cancers (53% and 74%, respectively) are much lower than for&hellip;\n","protected":false},"author":2,"featured_media":795752,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[64,63,137],"class_list":["post-795751","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-au","tag-australia","tag-health"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/795751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=795751"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/795751\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/795752"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=795751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=795751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=795751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}